Best GLP-1 Providers in Rhode Island (2026)

See by medication

Looking for a specific GLP-1? Browse Rhode Island providers by drug.

About GLP-1s in Rhode Island

Rhode Island allows telehealth GLP-1 prescribing. Rhode Island Medicaid covers GLP-1s for both diabetes and obesity with prior authorization.

• •Rhode Island's adult obesity rate is 30.0%
• •RI Medicaid covers GLP-1s with prior authorization
• •Providence is a regional Northeast telehealth hub

Top Cities for GLP-1 Treatment in Rhode Island

Telehealth providers ship to all Rhode Island addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Rhode Island GLP-1 clinic directory →

Insurance & Medicaid in Rhode Island

Most insurance plans in Rhode Island cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $219/mo.

For the exact criteria, drug list, and appeal process, read our Rhode Island Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Rhode Island

According to CDC data, 30% of Rhode Island adults have obesity (BMI of 30 or higher). This places Rhode Island at #35 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Rhode Island residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions